{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:00:32Z","timestamp":1793520032610,"version":"4.5.0"},"reference-count":26,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0428","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T22:36:26Z","timestamp":1549319786000},"page":"379-385","source":"Crossref","is-referenced-by-count":5,"title":["Parathyroid adenoma with prominent lymphocytic infiltrate having histological features highly suggestive of IgG4-related disease: a case report and literature review"],"prefix":"10.1507","volume":"66","author":[{"given":"Minsun","family":"Jung","sequence":"first","affiliation":[{"name":"Department of Pathology, Seoul National University Hospital, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Mo","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seoul National University Hospital, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Kyung","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seoul National University Hospital, Seoul 03080, Republic of Korea"},{"name":"Department of Pathology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong Cheon","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seoul National University Hospital, Seoul 03080, Republic of Korea"},{"name":"Department of Pathology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Wook","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kyung","family":"Won","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seoul National University Hospital, Seoul 03080, Republic of Korea"},{"name":"Department of Pathology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Veress B, Nordenstrom J (1994) Lymphocytic infiltration and destruction of parathyroid adenomas: a possible tumour-specific autoimmune reaction in two cases of primary hyperparathyroidism. Histopathology 25: 373\u2013377.","DOI":"10.1111\/j.1365-2559.1994.tb01356.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Lawton TJ, Feldman M, LiVolsi VA (1998) Lymphocytic infiltrates in solitary parathyroid adenomas: a report of four cases with review of the literature. Int J Surg Pathol 6: 5\u20139.","DOI":"10.1177\/106689699800600103"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Lam KY, Chan AC, Lo CY (2000) Parathyroid adenomas with pronounced lymphocytic infiltration: no evidence of autoimmune pathogenesis. Endocr Pathol 11: 77\u201383.","DOI":"10.1385\/EP:11:1:77"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kovacs K, Bell CD, Juco J, Rotondo F, Anderson J (2007) Parathyroid chief cell adenoma associated with massive chronic parathyroiditis in a woman with hyperparathyroidism. Endocr Pathol 18: 42\u201345.","DOI":"10.1007\/s12022-007-0001-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Fallone E, Bourne PA, Watson TJ, Ghossein RA, Travis WD, et al. (2009) Ectopic (mediastinal) parathyroid adenoma with prominent lymphocytic infiltration. Appl Immunohistochem Mol Morphol 17: 82\u201384.","DOI":"10.1097\/PAI.0b013e31817e7d6e"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Iliadis A, Koletsa T, Kostopoulos I, Karayannopoulou G (2015) Parathyroid adenoma with prominent lymphocytic infiltrate. Case Rep Pathol 2015: 705843.","DOI":"10.1155\/2015\/705843"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Bilezikian JP, Bandeira L, Khan A, Cusano NE (2018) Hyperparathyroidism. Lancet 391: 168\u2013178.","DOI":"10.1016\/S0140-6736(17)31430-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P (2015) Autoimmune thyroid disorders. Autoimmun Rev 14: 174\u2013180.","DOI":"10.1016\/j.autrev.2014.10.016"},{"key":"9","unstructured":"9 Erickson LA (2012) Chronic parathyroiditis. In: Nos\u00e9 V, Erickson LA, Tischler AS, Asa SL, Lopes MBS (eds) Diagnostic pathology: endocrine (1<sup>st<\/sup>). AMIRSYS, Salt Lake City: 2-24-2-27."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Weyand CM, Berry GJ, Goronzy JJ (2018) The immunoinhibitory PD-1\/PD-L1 pathway in inflammatory blood vessel disease. J Leukoc Biol 103: 565\u2013575.","DOI":"10.1189\/jlb.3MA0717-283"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Mezache L, Magro C, Hofmeister C, Pichiorri F, Sborov D, et al. (2017) Modulation of PD-L1 and CD8 activity in idiopathic and infectious chronic inflammatory conditions. Appl Immunohistochem Mol Morphol 25: 100\u2013109.","DOI":"10.1097\/PAI.0000000000000298"},{"key":"12","unstructured":"12 DeLellis RA, Arnold A, Eng C, Erickson LA, Franssila KO, <i>et al.<\/i> (2017) Parathyroid adenoma. In: Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J (eds) WHO classification of Tumours of Endocrine Organs (4<sup>th<\/sup>). IARC, Lyon: 153\u2013158."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Quinn CE, Healy J, Lebastchi AH, Brown TC, Stein JE, et al. (2015) Modern experience with aggressive parathyroid tumors in a high-volume New England referral center. J Am Coll Surg 220: 1054\u20131062.","DOI":"10.1016\/j.jamcollsurg.2014.10.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Karaarslan S, Yurum FN, Kumbaraci BS, Pala EE, Sivrikoz ON, et al. (2015) The role of parafibromin, galectin-3, HBME-1, and Ki-67 in the differential diagnosis of parathyroid tumors. Oman Med J 30: 421\u2013427.","DOI":"10.5001\/omj.2015.84"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hosny Mohammed K, Siddiqui MT, Willis BC, Zaharieva Tsvetkova D, Mohamed A, et al. (2017) Parafibromin, APC, and MIB-1 are useful markers for distinguishing parathyroid carcinomas from adenomas. Appl Immunohistochem Mol Morphol 25: 731\u2013735.","DOI":"10.1097\/PAI.0000000000000378"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Cho M, Oweity T, Brandler TC, Fried K, Levine P (2017) Distinguishing parathyroid and thyroid lesions on ultrasound-guided fine-needle aspiration: a correlation of clinical data, ancillary studies, and molecular analysis. Cancer Cytopathol 125: 674\u2013682.","DOI":"10.1002\/cncy.21888"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 de Matos LL, Del Giglio AB, Matsubayashi CO, de Lima Farah M, Del Giglio A, et al. (2012) Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis. Diagn Pathol 7: 97.","DOI":"10.1186\/1746-1596-7-97"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Barut F, Onak Kandemir N, Bektas S, Bahadir B, Keser S, et al. (2010) Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19. Endocr Pathol 21: 80\u201389.","DOI":"10.1007\/s12022-010-9114-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Zhu X, Sun T, Lu H, Zhou X, Lu Y, et al. (2010) Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma. J Clin Pathol 63: 786\u2013789.","DOI":"10.1136\/jcp.2010.076901"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, et al. (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25: 1181\u20131192.","DOI":"10.1038\/modpathol.2012.72"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Weindorf SC, Frederiksen JK (2017) IgG4-related disease a reminder for practicing pathologists. Arch Pathol Lab Med 141: 1476\u20131483.","DOI":"10.5858\/arpa.2017-0257-RA"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Stan MN, Sonawane V, Sebo TJ, Thapa P, Bahn RS (2017) Riedel\u2019s thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf) 86: 425\u2013430.","DOI":"10.1111\/cen.13238"},{"key":"23","unstructured":"23 Hao M, Liu M, Fan G, Yang X, Li J (2016) Diagnostic value of serum IgG4 for IgG4-related disease: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 95: e3785."},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Takeshima K, Inaba H, Furukawa Y, Nishi M, Yamaoka H, et al. (2014) Elevated serum immunoglobulin G4 levels in patients with Graves\u2019 disease and their clinical implications. Thyroid 24: 736\u2013743.","DOI":"10.1089\/thy.2013.0448"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Hiratsuka I, Yamada H, Itoh M, Shibata M, Takayanagi T, <i>et al.<\/i> (2018) Changes in serum immunoglobulin G4 levels in patients with newly diagnosed Graves\u2019 disease. Exp Clin Endocrinol Diabetes [Epub ahead of print]. doi: 10.1055\/a-0669-9333.","DOI":"10.1055\/a-0669-9333"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, et al. (2014) Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343: 152\u2013157.","DOI":"10.1126\/science.1246886"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/4\/66_EJ18-0428\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T11:30:37Z","timestamp":1694604637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/4\/66_EJ18-0428\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0428","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}